Lymphoma Clinical Trials in Bologna, Bologna
10 recruitingBologna, Bologna, Italy
Showing 1–10 of 10 trials
Recruiting
National Epidemiology of Cutaneous Lymphomas
Lymphoma With Cutaneous Involvement
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled1 locationNCT07463989
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled265 locationsNCT06191744
Recruiting
Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.
Breast CancerHodgkin Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled1 locationNCT07270679
Recruiting
Phase 2Phase 3
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Karyopharm Therapeutics Inc501 enrolled57 locationsNCT04442022
Recruiting
Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Marginal Zone Lymphoma (MZL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna59 enrolled15 locationsNCT06823960
Recruiting
Italian Study of Patients With Lymphoma
Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,500 enrolled1 locationNCT06814925
Recruiting
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Marginal Zone B-Cell Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna160 enrolled1 locationNCT06806488
Recruiting
Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context
Primary Mediastinal B Cell Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled3 locationsNCT06781450
Recruiting
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
Diffuse Large B-Cell Lymphoma (DLBCL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna96 enrolled11 locationsNCT06782789
Recruiting
Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
LymphomaLymphoproliferative Syndrome, Autoimmune
IRCCS Azienda Ospedaliero-Universitaria di Bologna5,500 enrolled1 locationNCT06781437